ROBERTO, MICHELA

ROBERTO, MICHELA  

DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE  

Mostra prodotti
Risultati 1 - 20 di 64 (tempo di esecuzione: 0.11 secondi).
Titolo Data di pubblicazione Autore(i) File
A 17-gene expression signature for early identification of poor prognosis in clear cell renal cell carcinoma 2022 Bassanelli, M.; Borro, M.; Roberto, M.; Giannarelli, D.; Giacinti, S.; Di Martino, S.; Ceribelli, A.; Russo, A.; Aschelter, A.; Scarpino, S.; Montori, A.; Pescarmona, E.; Tomao, S.; Simmaco, M.; Cognetti, F.; Milella, M.; Marchetti, P.
5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine 2020 Botticelli, A.; Scagnoli, S.; Roberto, M.; Lionetto, L.; Cerbelli, B.; Simmaco, M.; Marchetti, P.
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX 2016 Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma 2018 Falcone, Rosa; Roberto, Michela; Filetti, Marco; Anselmi, Elisabetta; Marchetti, Paolo
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial 2016 Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study 2015 Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P.
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer? 2013 Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer 2021 Piras, Marta; Panebianco, Martina; Garibaldi, Matteo; Roberto, Michela; Merlonghi, Gioia; Pellegrini, Patrizia; Marchetti, Paolo
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer. Potential molecular mechanisms, clinical implications and future perspectives 2021 Roberto, M.; Astone, A.; Botticelli, A.; Carbognin, L.; Cassano, A.; D'Auria, G.; Fabbri, A.; Fabi, A.; Gamucci, T.; Krasniqi, E.; Minelli, M.; Orlandi, A.; Pantano, F.; Paris, I.; Pizzuti, L.; Portarena, I.; Salesi, N.; Scagnoli, S.; Scavina, P.; Tonini, G.; Vici, P.; Marchetti, P.
Circulating tumor cells count predicts survival in colorectal cancer patients. 2014 Romiti, Adriana; Raffa, Salvatore; R., Di Rocco; Roberto, Michela; Milano, Annalisa; A., Zullo; Leone, Laura; Ranieri, Danilo; F., Mazzetta; E., Medda; I., Sarcina; Barucca, Viola; C., D'Antonio; V., Durante; Ferri, Mario; Torrisi, Maria Rosaria; Marchetti, Paolo
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study 2019 Mazzuca, F.; Roberto, M.; Arrivi, G.; Sarfati, E.; Schipilliti, F. M.; Crimini, E.; Botticelli, A.; Di Girolamo, M.; Muscaritoli, M.; Marchetti, P.
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma 2015 Roberto, Michela; Bassanelli, Maria; Iannicelli, Elsa; Giacinti, Silvana; D'Antonio, Chiara; Aschelter, Anna Maria; Marchetti, Paolo
clinicAl outcomes in pAtients with colorectAl cAncer And liver metAstAses: “the times they Are A-chAnging” 2013 Romiti, A; Milano, Annalisa; Balducci, G; Ferri, M; Roberto, Michela; D’Antonio, C; Durante, V; Mazzuca, F; Marchetti, P; Ziparo, V.
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial 2020 Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib 2018 Sgroi, V.; Bassanelli, M.; Roberto, M.; Iannicelli, E.; Porrini, R.; Pellegrini, P.; Tafuri, A.; Marchetti, P.
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer 2015 Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo
Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 2020 Falcone, R.; Sponziello, M.; Carletti, R.; Di Gioia, C.; Nardi, F.; Mio, C.; Pecce, V.; Abballe, L.; Grani, G.; Ramundo, V.; Damante, G.; Durante, C.; Filetti, M.; Roberto, M.; Marchetti, P.; Verrienti, A.
Current achievements and future perspectives of metronomic chemotherapy 2017 Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents 2019 Rossi, A.; Roberto, M.; Panebianco, M.; Botticelli, A.; Mazzuca, F.; Marchetti, P.
Drug–drug interactions and pharmacogenomic evaluation in colorectal cancer patients. The new drug-pin® system comprehensive approach 2021 Roberto, M.; Rossi, A.; Panebianco, M.; Pomes, L. M.; Arrivi, G.; Ierino, D.; Simmaco, M.; Marchetti, P.; Mazzuca, F.